Therefore, GLP-1RA is a promising group of medications to treat obesity, improve glycemic control, and decrease the risk of complications in these patients
Aim for at least 30 minutes of moderate exercise most days of the week
According to published data, in Phase III studies involving adults with obesity or overweight conditions, patients receiving a 12 mg dose achieved an average weight reduction of 28.3% over 80 weeks
Hargens ordered a pack and after a few weeks of using them, she noticed she was eating less and spending less time thinking about food
Private employer plan GLP-1 coverage for obesity has become a major benefits policy debate, with large employers balancing the cost of GLP-1 coverage against documented workforce health and productivity benefits
Analysts at Morgan Stanley have predicted that the impact of these drugs on peoples lifestyles and the market will be long-lasting